/ IHRights#Iran: Hossein Amaninejad and Hamed Yavari were executed in Hamedan Central Prison on 11 June. Hossein was arrested… https://t.co/3lnMTwFH6z13 Jun

Mohammad Hossein Geravand and Kiumars Gholami Executed in Karaj

8 Jan
Mohammad Hossein Geravand and Kiumars Gholami Executed in Karaj

Iran Human Rights (IHRNGO); January 8, 2024: Mohammad Hossein Geravand and Kiumars Gholami, two men on death row for drug-related charges, were executed in Ghezelhesar Prison.

According to information obtained by Iran Human Rights, two men were executed in Ghezelhesar Prison in Karaj on 8 January. Their identities have been established as Mohammad Hossein Geravand and Kiumars Gholami who were sentenced to death for drug-related charges by the Revolutionary Court.

They were transferred from Ward 2 of the prison to solitary confinement in preparation for their executions the day prior.

At the time of writing, neither of their executions have been reported by domestic media or officials in Iran.

On 21 December, IHRNGO warned of more drug executions being carried out after an Iranian MP from Lorestan province stated that the cases of 1000-2000 drug death row inmates were at implementation stage.

Drug-related executions have continuously risen every year for the past three years. At least 305 people were executed for drug-related charges between 1 January-10 October 2023, a 69% increase compared to the same period in 2022, and the number of drug-related executions in 2023 were close to 20 times higher than 2020.

The number of drug executions dramatically dropped in 2018 following a 2017 Amendment to the Anti-Narcotics Laws. Consequently, drug executions ranged between 24-30 per annum between 2018-2020. The Amendment was reversed in practice in 2021 when executions increased ten-fold to 126 in 2021 and doubled again in 2022 with 256 drug-related executions. On 13 September 2023, IHRNGO reported a 94% rise in the number of drug-related executions in the year following the start of the “Woman, Life, Freedom” movement in September 2022.